SCHEMBL10064053

SCHEMBL10064053

CC(=O)OC[C@H]1O[C@@H](n2cnc(N)nc2=O)CC1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 2/20 0.70
ADRB1 P08588 1/20 0.70
POLB P06746 3/20 0.46
LMNA P02545 3/20 0.46
TP53 P04637 3/20 0.46
HTT P42858 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GMNN O75496 1/20 0.46
NFKB1 P19838 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
RAB9A P51151 1/20 0.46
BLM P54132 1/20 0.46
HBB P68871 1/20 0.46
PMP22 Q01453 1/20 0.46
NT5E P21589 1/20 0.44
PNP P00491 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE3A Q14432 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13376153 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL9999665 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL3843980 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL118663 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL10063813 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL19059873 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL118662 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL9999640 0.88 DNMT1 (0.56) DNMT1ADRB1POLBLMNATP53
SCHEMBL16366026 0.88 DNMT1 (0.74) DNMT1ADRB1POLBLMNATP53
SCHEMBL10064225 0.88 DNMT1 (0.74) DNMT1ADRB1POLBLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046457-A1 PREPARATION OF DECITABINE DR. REDDY'S LABORATORIES, INC. (US) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046457-A1 PREPARATION OF DECITABINE DNMT3A, DNMT1, DNMT3B DNMT1 2/4885ADRB1 4149/4885POLB 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.